BioLineRx Ltd (BLRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BioLineRx Ltd.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
BLRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- BLRX has a lower percent of analysts bearish on the stock than nearly 100% of all US stocks.
- BioLineRx Ltd's upside potential (average analyst target price relative to current price) is greater than 92.73% of all US stocks.
- BioLineRx Ltd's variance in analysts' estimates is less than 7.59% of stocks in the micro market cap category.
- The number of analysts covering the stock of BLRX is higher than 13.2% of Pharmaceutical Products stocks.
- BioLineRx Ltd's average analyst price target is greater than 17.15% of all US stocks.
- BLRX has a higher percentage of analysts bullish on the stock than 82.08% of all US stocks.
- BioLineRx Ltd's change in bullishness amongst analysts is lower than nearly 100% of all US stocks.
What is the outlook for BLRX? Use POWR Ratings for clearer insight into price direction.